ATRMec1 phosphorylation-independent activation of Chk1 in vivo

Yinhuai Chen1, Julie M Caldwell1, Elizabeth Pereira1

  • 1Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, New Hampshire 03755 and Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0524.

Insights

The protein kinase Chk1 is vital for DNA damage response. A specific C-terminal mutation bypasses the need for ATR/Mec1 phosphorylation, enabling Chk1 checkpoint function.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • The protein kinase Chk1 is crucial for cellular defense against DNA damage and replication stress.
  • Current models suggest ATR/Mec1 phosphorylates Chk1's C-terminal domain, but its activation mechanism and C-terminus function remain unclear.

Purpose of the Study:

  • To investigate the role of the Chk1 C-terminus in DNA damage and replication block response in vivo.
  • To elucidate the mechanism of Chk1 activation and the significance of ATR/Mec1 phosphorylation sites.

Main Methods:

  • Utilized an in vivo assay to study Chk1 C-terminus function.
  • Introduced mutations in ATR/Mec1 phosphorylation sites and specific C-terminal amino acids.
  • Assessed cell viability and Chk1 kinase activity in vitro.

Main Results:

  • ATR/Mec1 phosphorylation sites are essential for checkpoint response and cell viability during replication stress.
  • Loss of these phosphorylation sites did not affect Chk1 kinase activity in vitro.
  • A single amino acid substitution in the C-terminus restored viability and bypassed the need for ATR/Mec1 phosphorylation for Chk1 activation.

Conclusions:

  • The Chk1 C-terminus plays a critical role in checkpoint activation.
  • A specific C-terminal mutation can allosterically alter Chk1, bypassing the requirement for ATR/Mec1 phosphorylation sites for checkpoint function.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...